HMGB1 and chronic myelogenous leukemia, BCR-ABL1 positive: Hence, we may speculate that RAGE, receptor for advanced glycation end-products and its proinflammatory ligands such as: HMGB1, S100B and CML contribute to ALS pathogenesis.